KEAP1 and Parkinson disease: Moreover, it quercetin-modified ultrasmall Cu2-xSe nanoparticles can activate the Nrf2/Keap1/p62 signaling pathway in neurons, thereby improving the motor dysfunction in patients with Parkinson’s disease [76].